Pulmatrix, Inc. (PULM)

Pulmatrix Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	7.3	6.07	5.17	12.63	7.91
Revenue Growth (YoY)	20.21%	17.45%	-59.09%	59.72%	5069.93%
Gross Profit	7.3	6.07	5.17	12.63	7.91
Selling, General & Admin	6.52	6.78	6.38	6.89	8.49
Research & Development	15.52	18.24	15.38	15.61	12.85
Other Operating Expenses	0	0	3.58	0	7.27
Operating Expenses	22.04	25.02	25.34	22.5	28.6
Operating Income	-14.74	-18.95	-20.17	-9.86	-20.69
Other Expense / Income	-0.62	-0.11	0	9.45	-0.1
Pretax Income	-14.12	-18.84	-20.17	-19.31	-20.6
Net Income	-14.12	-18.84	-20.17	-19.31	-20.6
Preferred Dividends	0	0	3.2	0	0
Net Income Common	-14.12	-18.84	-23.37	-19.31	-20.6
Shares Outstanding (Basic)	4	3	3	1	1
Shares Outstanding (Diluted)	4	3	3	1	1
Shares Change	5.92%	27.29%	88.40%	71.83%	305.53%
EPS (Basic)	-3.87	-5.46	-8.63	-13.43	-24.60
EPS (Diluted)	-3.87	-5.46	-8.63	-13.43	-24.60
Free Cash Flow	-16.66	-19.44	-19.87	-12.76	3.17
Free Cash Flow Per Share	-4.56	-5.64	-7.34	-8.88	3.79
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-201.97%	-312.09%	-390.15%	-78.06%	-261.59%
Profit Margin	-193.49%	-310.26%	-452.08%	-152.83%	-260.38%
Free Cash Flow Margin	-228.30%	-320.24%	-384.43%	-101.03%	40.10%
EBITDA	-12.65	-17.29	-18.94	-18.27	-19.83
EBITDA Margin	-173.28%	-284.81%	-366.32%	-144.57%	-250.71%
Depreciation & Amortization	1.48	1.55	1.24	1.04	0.77
EBIT	-14.12	-18.84	-20.17	-19.31	-20.6
EBIT Margin	-193.49%	-310.26%	-390.23%	-152.83%	-260.38%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).